Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2007 Nov 15;1:13. doi: 10.1186/1753-2000-1-13

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2007 Schlander; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Projected prescription drug expenditures for ADHD in children and adolescents, 2001 – 2012 (base case). a, b: Defined daily doses (DDDs) p.a.; c, d: expenditures by category p.a.; e, f: total (cumulated) expenditures p.a.; left: England; right: Germany. MPH: methylphenidate; IR: immediate-release formulations (Ritalin^R, branded generics [Equasym^R, Medikinet^R], generics; Focalin^R); MR: modified-release formulations (Concerta^RXL, Equasym^RXL, Medikinet^Rretard, Focalin^RXR; MPH-Patch: transdermal system (Daytrana^R); LisDEX: lisdexamphetamine (NRP104); Nonstimulants: atomoxetine (Strattera^R), armodafinil (Nuvigil^R); DEX: dexamphetamine (England only).